Blair William & CO Aravive, Inc. Transaction History

Blair William & CO

  • $32 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.19 - $4.07 $94,170 - $175,010
-43,000 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$4.65 - $6.42 $13,950 - $19,260
3,000 Added 7.5%
43,000 $257,000
Q1 2021

May 13, 2021
BUY
$5.11 - $9.24 $20,440 - $36,960
4,000 Added 11.11%
40,000 $264,000
Q4 2020

Feb 09, 2021
BUY
$4.36 - $6.51 $156,960 - $234,360
36,000 New
36,000 $203,000

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email